Endocrine

CJC-1295 is a synthetic analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in growth hormone– and insulin-like growth factor 1 (IGF-1)–associated signaling pathways. Experimental studies have examined how incorporation of a Drug Affinity Complex (DAC) may extend the peptide’s plasma persistence, allowing prolonged observation of GH–IGF axis dynamics under controlled laboratory conditions. In preclinical experimental settings, CJC-1295 has been explored in relation to: – protein synthesis–associated anabolic signaling– lipid metabolism and body composition–related biochemical pathways

Modified GRF is a truncated peptide analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in GHRH-mediated signaling pathways. In experimental settings, Modified GRF has been explored in relation to: – muscle repair– and growth-associated cellular signaling – wound-associated tissue remodeling processes – bone metabolism and structural signaling pathways – lipid metabolism and fat-oxidation–related biochemical pathways – metabolic regulation–associated signaling networks – glucose homeostasis– and immune-related regulatory pathways

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health   FRESHLY PREPARED SOLUTION 

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health  

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration. Experimental and preclinical research indicates that modulation of this pathway influences muscle and tissue dynamics associated with repair and adaptation. According to research-based observations, GDF-8 has been associated with the following effects: Enhancement of muscular regeneration and recovery processes following injury Support of the body’s regenerative capacity at the tissue level Increase in myofiber hypertrophy in experimental models

GHRP-2 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its targeted receptor activity, GHRP-2 remains a compound of interest in experimental models investigating signaling mechanisms related to growth hormone regulatory pathways and systemic endocrine coordination.

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

HGH (191 AA) is a recombinant peptide hormone studied in research contexts for its role in endocrine signaling and systemic physiological regulation. It is associated with complex signaling pathways involved in cellular communication, metabolic coordination, and tissue-level regulatory processes. Due to its broad receptor distribution and multi-system activity, HGH remains a key subject of investigation in experimental models exploring integrative endocrine and metabolic mechanisms.  

HGH Fragment (176–191) is a synthetic peptide derived from the C-terminal region of human growth hormone. It is studied in research contexts for its selective interaction with signaling pathways associated with lipid metabolism and energy regulation. Unlike full-length HGH, this fragment demonstrates a more targeted activity profile, making it a subject of investigation in experimental models focused on metabolic signaling and pathway-specific regulatory mechanisms.

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1, designed to exhibit modified binding characteristics and extended activity in research environments. It is studied for its interaction with cellular signaling pathways involved in growth factor regulation, intercellular communication, and system-wide biological coordination. Due to its structural modifications and prolonged activity profile, IGF-1 LR3 remains a key compound in experimental models investigating complex signaling dynamics and regulatory mechanisms at the cellular level.

Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue and a ghrelin receptor (GHS-R1a) agonist. It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its selective receptor activity profile, ipamorelin remains a compound of interest in experimental models investigating growth hormone–related signaling and neuroendocrine regulatory mechanisms.

Kisspeptin is a naturally occurring peptide in humans that has been extensively studied for its role in hormonal signaling associated with puberty and reproductive function. In research settings, it has also been linked to regulatory processes involving renal function, angiogenesis, testosterone modulation, and mood- and behavior-related neural pathways. The peptide has been identified in the brain and has been investigated for its association with mechanisms that limit tumor development and metastatic progression in experimental models. Of particular scientific interest is kisspeptin’s ability to influence gonadotropin-releasing hormone (GnRH) signaling, positioning it as a key regulator within the neuroendocrine system. Additional research suggests that kisspeptin may be involved in biological processes relevant to aging and age-associated functional changes.

Melanotan 1 is a synthetic peptide originally developed as an analog of alpha-melanocyte-stimulating hormone (α-MSH) to study sunless pigmentation mechanisms. Subsequent experimental and preclinical research has shown that Melanotan 1 interacts with multiple melanocortin pathways, resulting in a range of physiological effects beyond skin pigmentation. These include modulation of signaling pathways involved in cardiovascular regulation, appetite and energy balance, and central nervous system function. Ongoing research continues to explore the broader biological roles of Melanotan 1 across multiple physiological systems.

Experimental and preclinical studies suggest that Melanotan-2 is associated with several biological effects mediated through the melanocortin receptor system, including: Regulation of skin pigmentation processes related to tanning Modulation of neurobehavioral pathways linked to sexual arousal Influence on appetite control and satiety signaling Interaction with neural mechanisms involved in compulsive behavior Modulation of metabolic pathways related to glucagon signaling Effects explored in research models relevant to autism-associated traits Influence on reward and reinforcement pathways studied in addiction research

MIF-1 (Melanocyte-Inhibiting Factor 1) has been investigated for its role in central nervous system signaling and neuronal regulation. Scientific studies have examined MIF-1 in relation to multiple biological processes associated with brain function, neurochemical balance, and cellular resilience. Research has primarily focused on MIF-1 in the context of the following areas: Neurotransmitter Modulation: Associated with the regulation of dopamine and serotonin signaling pathways involved in motor function and mood-related processes. Neuroplasticity: Linked to mechanisms that support synaptic plasticity relevant to learning and memory in experimental research. Neuroprotective Activity: Studied for its involvement in cellular pathways that help protect neurons from oxidative and inflammatory stress. Neuroregenerative Processes: Investigated for its role in mechanisms related to neuronal repair and cellular renewal in research models of neural injury. Mood-Related Signaling: Explored for its influence on neurochemical pathways associated with emotional regulation and stress responses. Cognitive Function: Associated in experimental settings with processes relevant to memory, attention, and higher-order cognitive performance. Neurodegenerative Research: Examined in studies focused on biological pathways involved in neurodegenerative conditions and age-related neural changes.

MIF-1 (Melanocyte-Inhibiting Factor 1) has been investigated for its role in central nervous system signaling and neuronal regulation. Scientific studies have examined MIF-1 in relation to multiple biological processes associated with brain function, neurochemical balance, and cellular resilience. Research has primarily focused on MIF-1 in the context of the following areas: Neurotransmitter Modulation: Associated with the regulation of dopamine and serotonin signaling pathways involved in motor function and mood-related processes. Neuroplasticity: Linked to mechanisms that support synaptic plasticity relevant to learning and memory in experimental research. Neuroprotective Activity: Studied for its involvement in cellular pathways that help protect neurons from oxidative and inflammatory stress. Neuroregenerative Processes: Investigated for its role in mechanisms related to neuronal repair and cellular renewal in research models of neural injury. Mood-Related Signaling: Explored for its influence on neurochemical pathways associated with emotional regulation and stress responses. Cognitive Function: Associated in experimental settings with processes relevant to memory, attention, and higher-order cognitive performance. Neurodegenerative Research: Examined in studies focused on biological pathways involved in neurodegenerative conditions and age-related neural changes. FRESHLY PREPARED SOLUTION 

Note: Due to N-acetylation and amidation, the peptide exhibits reduced polarity, which may result in lower water solubility compared to unmodified Epitalon.N-Acetyl Epitalon Amidate is a synthetically modified derivative of Epitalon (epithalamin), obtained through N-acetylation and C-terminal amidation. The acetylation and amidation modifications applied to N-acetyl Epitalon Amidate have been studied for their ability to confer enhanced molecular stability, extended half-life, and improved receptor interaction compared to the unmodified peptide. Epitalon and its modified forms have been extensively studied in relation to cellular aging processes, telomere biology, circadian regulation, and genomic stability. In particular, research has examined this peptide in the context of the following biological areas: Telomerase-related pathways Cellular stress resistance Endocrine and circadian regulation Stress hormone modulation Antioxidant activity Central nervous system function Longevity-related processes

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects:Exhibits anti-inflammatory properties that support wound healing and tissue regenerationEnhances trust, empathy, and social recognition involved in interpersonal bondingImproves recognition of emotional expressions, supporting effective social communicationModulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reductionHas been investigated for potential roles in reducing symptoms associated with anxiety and depressive statesContributes to sexual receptivity and reproductive behaviors in both men and womenReduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding

Oxytocin is a multifunctional peptide hormone and neuropeptide involved in a wide range of physiological and psychological processes. Synthesized in the hypothalamus and released by the posterior pituitary gland, it acts both peripherally and within the central nervous system. Research has associated oxytocin with the following effects: Exhibits anti-inflammatory properties that support wound healing and tissue regeneration Enhances trust, empathy, and social recognition involved in interpersonal bonding Improves recognition of emotional expressions, supporting effective social communication Modulates neurotransmitter systems such as dopamine and serotonin, contributing to mood balance and stress reduction Has been investigated for potential roles in reducing symptoms associated with anxiety and depressive states Contributes to sexual receptivity and reproductive behaviors in both men and women Reduces activity of the amygdala, which is associated with fear and anxiety responsesInduces uterine contractions during labor and mediates milk ejection during breastfeeding FRESHLY PREPARED SOLUTION 

Pegylated Mechano Growth Factor (PEG-MGF) is a modified splice variant related to insulin-like growth factor-1    (IGF-1). In experimental research settings, PEG-MGF has been studied for its role in supporting myoblast division and facilitating the fusion and maturation of muscle fibers. Pegylation enhances the peptide’s stability and circulating half-life, allowing prolonged biological activity compared to non-pegylated MGF. Based on preclinical and experimental studies, PEG-MGF has been investigated in relation to the following biological processes: Support of muscle tissue remodeling Stimulation of new muscle cell formation Neuroprotective mechanisms in experimental models Cardioprotective pathways associated with cellular survival Processes involved in wound healing and tissue regeneration Bone repair and osteogenic activity in injury models Regulation of body fat metabolism and lipid-related markers Modulation of immune-related cellular responses

Bremelanotide, also known as PT-141, is a synthetic peptide structurally related to alpha-MSH and melanocortin signaling molecules. It acts as an agonist of the MC3R and MC4R melanocortin receptors, which are involved in central nervous system pathways regulating motivation and arousal. By activating these receptors, PT-141 stimulates hypothalamic and related brain regions associated with sexual interest and behavioral response. Research indicates that its activity is centrally mediated rather than dependent on peripheral vascular mechanisms. While initially explored for sexual function in both men and women, scientific studies have shown particular relevance in premenopausal women experiencing conditions related to reduced sexual desire or arousal. According to research observations, PT-141 (Bremelanotide) has been associated with: Increased sexual desire and libido Higher frequency of sexual activity Support of erectile response in men with erectile dysfunction or impotence Potential benefit in premenopausal women with hypoactive sexual desire disorder Support in female sexual arousal–related dysfunctions Increased subjective energy and vitality levels

INDEPENDENTLY TESTED • VERIFIED QUALITY ✓ Purity — HPLC analysis ✓ Identity — Mass spectrometry ✓ Net content — Verified on the 6 mg vial RETA 6 mg and 10 mg share the same peptide batch. The tested sample was a 6 mg vial. VERIFY COA AT FREEDOM DIAGNOSTICS → Enter search code: Suaw2605040577Reta is a next-generation metabolic research peptide classified as a multi-receptor agonist designed to interact with GLP-related, GIP-associated, and glucagon-mediated signaling pathways. By targeting multiple receptor systems simultaneously, it has become a key subject of investigation in studies focused on integrative metabolic regulation, energy balance, and complex signaling networks. Its molecular structure has been engineered to enhance stability and albumin binding, supporting an extended activity profile and improved pharmacokinetic characteristics in research environments. Current research explores its role in multi-pathway signaling dynamics, systemic regulatory processes, and advanced metabolic communication mechanisms.